Breaking News

LSNE Completes PAI at Bedford Facility

Will produce sterile drug product

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Lyophilization Services of New England, Inc. (LSNE) has completed a successful Pre-Approval Inspection (PAI) and GMP inspection, clearing the way for the company to manufacture commercial drug product for U.S. distribution. This is the second PAI at the Bedford, NH facility. The first inspection was for a bulk drug intermediate lyophilized in LSNE’s 260 sq.-ft. lyophilizer. Shawn Cain, chief operating officer of LSNE said, “The completion of this inspection is a critical milestone...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters